Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support

Area of Science:

• Cardiovascular Research
• Angiogenesis
• Vascular Biology

Background:

• Mechanisms of variable coronary collateral formation in patients with similar coronary artery disease patterns are not fully understood.
• This study explores the role of circulating humoral and cellular factors in this variation.

Purpose of the Study:

• To investigate the association between circulating factors and coronary collateral development.
• To determine if reduced endothelial progenitor cells (EPCs) or altered growth factor activity contribute to inadequate collateralization.

Main Methods:

• Assessed collateral flow index (CFI) in 30 patients with isolated left anterior descending coronary artery disease post-percutaneous coronary intervention.
• Measured coronary sinus growth factors, plasma angiogenic and mitogenic activity, and circulating CD34/CD133-positive hemopoietic precursor cells and differentiated EPCs.

Main Results:

• Patients with inadequate collateralization (CFI <0.25) showed lower growth factor concentrations and weaker plasma proangiogenic effects.
• A strong positive correlation was found between circulating hemopoietic precursor cells and CFI (r=0.75, P<0.001).
• Significantly reduced numbers of differentiated EPCs were observed in patients with inadequate collateralization (75% reduction in circulation, 70% in culture).

Conclusions:

• Inadequate coronary collateral development is associated with reduced circulating EPCs and impaired chemotactic/proangiogenic activity.
• Findings support therapeutic strategies aimed at augmenting circulating EPCs to enhance coronary collateral formation.